The company has received approval from the US Food and Drug Administration (USFDA) for Glycopyrrolate Injection, a generic equivalent of Hikma Pharmaceuticals#39; Robinul Injection, the Mumbai-based drug maker said in a statement.
The company has received approval from the US Food and Drug Administration (USFDA) for Glycopyrrolate Injection, a generic equivalent of Hikma Pharmaceuticals#39; Robinul Injection, the Mumbai-based drug maker said in a statement. The company has received approval from the US Food and Drug Administration (USFDA) for Glycopyrrolate Injection, a generic equivalent of Hikma Pharmaceuticals#39; Robinul Injection, the Mumbai-based drug maker said in a statement. Moneycontrol Latest News Read More
हिन्दी 
English